TCM
TCG Crossover Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
1,165.83%
This Fund
S&P 500
1 Year Est. Return
+1,165.83%
AUM
$3.5B
AUM Growth
+$474M
(+16%)
Holding
54
Top Buys
| 1 | +$94.1M | |
| 2 | +$93.1M | |
| 3 | +$85.6M | |
| 4 |
Vor Biopharma
VOR
|
+$80M |
| 5 |
Immunovant
IMVT
|
+$72.4M |
Top Sells
| 1 | +$87.5M | |
| 2 | +$74.6M | |
| 3 | +$65.3M | |
| 4 |
Structure Therapeutics
GPCR
|
+$53.4M |
| 5 |
Liquidia Corp
LQDA
|
+$48.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
EyePoint Inc
EYPT
$1.14B
| – | – |
-3,572,335
|
|
||
|
RAPT
52
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-2,582,408
|
|
||
|
VTYX
53
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-316,195
|
|
||
|
MAZE
54
Maze Therapeutics
MAZE
$1.46B
| – | – |
-173,816
|
|